Ostrum Asset Management Amgen Inc Transaction History

Ostrum Asset Management

$1.21 Trillion
Q3 2024

A detailed history of Ostrum Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Ostrum Asset Management holds 12,800 shares of AMGN stock, worth $3.57 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

12,800

Previous 16,485 22.35%

Holding current value

$3.57 Million

Previous $5.15 Billion 19.93%

% of portfolio

0.34%

Previous 0.45%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$309.38 - $337.38 $1.14 Million - $1.24 Million	-3,685 Reduced 22.35%	12,800 $4.12 Billion
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $112,982 - $137,303	-430 Reduced 2.54%	16,485 $5.15 Billion
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $829,463 - $1 Million	-3,085 Reduced 15.43%	16,915 $4.81 Billion
Q4 2023 Feb 13, 2024	SELL	$255.7 - $288.46 $1.52 Million - $1.71 Million	-5,931 Reduced 22.87%	20,000 $5.76 Billion
Q3 2023 Nov 14, 2023	SELL	$218.65 - $271.46 $83,961 - $104,240	-384 Reduced 1.46%	25,931 $6.97 Billion
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $62,352 - $73,730	-291 Reduced 1.09%	26,315 $5.84 Billion
Q1 2023 May 12, 2023	BUY	$225.79 - $275.2 $6.01 Million - $7.32 Million	26,606 New	26,606 $6.43 Billion
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $910,595 - $1.09 Million	-5,230 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $206,874 - $242,503	-1,241 Reduced 19.18%	5,230 $964,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $1.15 Million - $1.35 Million	6,471 New	6,471 $1.26 Million

Others Institutions Holding AMGN

# of Institutions

3,119

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ostrum Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Ostrum Asset Management with notifications on news.

Account

Ostrum Asset Management Amgen Inc Transaction History